Zhen-Ao Group is a large-scale high-tech group in health industry engaged mainly in developing nucleic acid products with contemporary biological technology and integrating R & D, production and sales of natural medicines, biological products, health-care foods, cosmetics and health-care textiles, etc. In 1996, Dalian Zhen-Ao Nucleic Acid Science & Technology Development Co., Ltd. was established, which was restructured into Dalian Zhen-Ao Bio-engineering Stock Co., Ltd. in Oct. 2000. In 2003, Zhen-Ao Group was registered as the largest nucleic acid industrialization base in China and a key high-tech enterprise in national Torch Plan. Now the total registered capital of Zhen-Ao Group has amounted to RMB 181.07 million. Zhen-Ao Group, as a parent company, consists of such five sub-companies as Dalian Zhen-Ao Pharmaceutical Co., Ltd., Fujian Zhen-Ao Nucleic Acid Co., Ltd., Shanghai Zhen-Ao HTB Biological Science & Technology Co., Ltd., Dalian Zhen-Ao Import & Export Co., Ltd. and Dalian Shuangdi Biological Science & Technology Company. Headquartered in Zhen-Ao Life Garden, DD Port, Dalian High-tech Park, Zhen-Ao Group covers land area of 380,000 m2 in which a scientific research center, a research institute and a provincial bioengineering research center are established. It has a scientific research building over 2,000 m2 equipped with fine domestic and foreign advanced scientific research equipment and testing instruments. There are three mid-trial bases in Dalian, Shanghai and Fuzhou with nearly one hundred workers engaged directly in R & D. Zhen-Ao Group always insists on the stratagem of technological research starting at high level and crossing over at rapid speed. With the tenet of “Base self upon life science to benefit human being’s health”, it develops, manufactures and sells health foods, restoratives, biochemicals, Chinese traditional medicines, cosmetics and other health products by the way to adopt modern biotechnology combining with Chinese traditional medical science with natural active materials, natural medicine as main developing target. It has acquired successively ISO9001 attestation, GMP attestation for medicines, GMP attestation for health-care foods, HACCP food safety prevention and control system attestation and ISO14001 environmental standard attestation. Internationally it has acquired FDA business registration and product customs inspection in USA and the health product accession attestation issued by Ministry of Health and Welfare Japan.